1262487-26-2

Upstream product

• 196302-92-8 1D-5-O-allyl-2,6-di-O-benzyl-3-O-endo,4-O-exo-(L-1',7',7'-trimethylbicyclo<2.2.1>hept-2'-ylidene)-myo-inositol 

Downstream Products

• 1262331-28-1 (-)-5-O-allyl-2,3,6-tri-O-benzyl-D-myo-inositol 1,4-O-bis(dibenzyl phosphate) 
• 1262331-29-2 (+)-2,3,6-tri-O-benzyl-5-O-(carboxymethyl)-D-myo-inositol 1,4-O-bis(dibenzyl phosphate) 
• 1262331-30-5 (-)-2,3,6-tri-O-benzyl-5-O-(sulfo)-D-myo-inositol 1,4-O-bis(dibenzyl phosphate) 
• 145842-31-5 (+)-2,3,6-tri-O-benzyl-D-myo-inositol 1,4-O-bis(dibenzyl phosphate) 
• 1262487-25-1 (-)-5-O-allyl-2,3,6-tris-O-benzyl-D-myo-inositol 

Relevant academic research and scientific papers

Development of inositol-based antagonists for the d-myo-inositol 1,4,5-trisphosphate receptor

The syntheses of four d-myo-inositol 1,4,5-trisphosphate (InsP3) derivatives, incorporating phosphate bioisosteres at the 5-position, are reported. The methyl phosphate ester and sulfate derivatives retain InsP 3 receptor (InsP3